LATAM III: Driver Alterations in Lung Cancer

Don’t miss Series III of our expert-led educational program, focusing on critical advancements in lung cancer treatment tailored for Latin America. This session features thought leaders addressing key topics such as adjuvant treatments from EGFR to new biomarkers, the evolving role of KRAS as a targetable mutation, and breakthroughs in targeted therapies for advanced disease and brain metastases. The program also highlights the opportunities and challenges of molecular profiling in the region and the importance of research and networking to strengthen regional collaboration.

Image